Nordic Capital Becomes Major Shareholder in Equashield
October 7, 2022
Nordic Capital has made a significant minority investment in Equashield to support the company's next phase of growth and global expansion. The partnership will help Equashield commercialize its automated compounding systems and scale its closed system transfer device (CSTD) business across healthcare markets.
- Buyers
- Nordic Capital
- Targets
- Equashield
- Industry
- Medical Devices
- Location
- New York, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Nordic Capital Acquires Majority Stake in IntegriChain from Accel-KKR
November 8, 2023
Cloud & SaaS
Nordic Capital has agreed to acquire a majority share in IntegriChain, a Philadelphia-based provider of a data-driven commercialization and market-access platform for the pharmaceutical industry, from Accel-KKR. The terms were not disclosed; closing is expected before year-end and is subject to customary regulatory and closing conditions.
-
Nordic Capital Acquires Majority Stake in Foxway
June 19, 2023
IT Services
Nordic Capital has signed an agreement to acquire a majority share in Foxway from Norvestor VII and other owners, with completion expected in Q3 2023 subject to customary closing conditions. Nordic Capital will partner with Foxway management and alongside Norvestor to support continued growth, international expansion and Foxway’s focus on circular IT services; Foxway is a Sweden‑headquartered provider of device refurbishment, asset recovery and lifecycle services with over 1,000 employees and SEK ~7.6bn in revenue (2022).
-
Strattam Capital Invests in SciShield
April 12, 2023
Software
Strattam Capital has made an equity investment in SciShield to accelerate product innovation and expand the company’s product, engineering, and customer success teams. SciShield, a Boston-based provider of environmental, health & safety (EHS) and chemical-inventory software for scientific laboratories, will use the capital to scale its platform and support growing customer demand across biotech, academic research institutions, and large pharmaceutical customers.
-
Nordic Capital and Astorg Acquire Cytel from New Mountain Capital
December 21, 2020
Healthcare Services
Nordic Capital and Astorg have agreed to jointly acquire Cytel Inc. from New Mountain Capital. Cytel, a Waltham, Massachusetts–based provider of clinical trial design software, biometrics services and advanced analytics with more than 1,500 employees, will continue to be led by CEO Josh Schultz while the new owners invest to accelerate product development and growth; terms were not disclosed.
-
EQT Acquires Minority Stake in SHL Medical
January 3, 2020
Medical Devices
EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.
-
GHO Capital Acquires Majority Stake in Sterling Pharma Solutions
February 28, 2019
Pharmaceuticals
GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.